The African Union (AU) has dropped plans to secure coronavirus vaccines from the Serum Institute of India and is instead exploring options with the US drug maker, Johnson & Johnson, APA reports citing BBC.
The head of Africa's Centres for Disease Control, John Nkengasong, says reliable supplies of vaccines were vital - and Indian restrictions on exports have complicated things for Africa.
He says the AU has already signed a deal for up to 400 million single dose jabs from Johnson & Johnson.
India's Serum Institute is licensed to make global supplies of the Oxford-AstraZeneca jab but Delhi has commandeered stocks to deal with surging infections.
Nkengasong says the AU's decision has nothing to do with the possible link to blood clots in rare cases involving the AstraZeneca vaccine, which will still be supplied to Africa through the UN's Covax scheme.